Operating Lease, Right-of-Use Asset of Sage Therapeutics, Inc. from 01 Jan 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sage Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Jun 2025.
  • Sage Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $9,957,000, a 716% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Sage Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $9,957,000 +$8,737,000 +716% 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 $10,357,000 +$7,500,000 +263% 31 Mar 2025 10-Q 29 Apr 2025 2025 Q1
Q4 2024 $10,753,000 +$6,295,000 +141% 31 Dec 2024 10-Q 30 Jul 2025 2025 Q2
Q3 2024 $11,251,000 +$5,225,000 +87% 30 Sep 2024 10-Q 29 Oct 2024 2024 Q3
Q2 2024 $1,220,000 -$6,340,000 -84% 30 Jun 2024 10-Q 31 Jul 2024 2024 Q2
Q1 2024 $2,857,000 -$6,205,000 -68% 31 Mar 2024 10-Q 25 Apr 2024 2024 Q1
Q4 2023 $4,458,000 -$6,074,000 -58% 31 Dec 2023 10-K 11 Feb 2025 2024 FY
Q3 2023 $6,026,000 -$5,944,000 -50% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $7,560,000 -$5,819,000 -43% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $9,062,000 -$5,697,000 -39% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $10,532,000 -$5,577,000 -35% 31 Dec 2022 10-K 14 Feb 2024 2023 FY
Q3 2022 $11,970,000 -$5,462,000 -31% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $13,379,000 -$5,349,000 -29% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $14,759,000 +$11,059,000 +299% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $16,109,000 -$8,955,000 -36% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q3 2021 $17,432,000 -$9,114,000 -34% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $18,728,000 -$9,271,000 -33% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $3,700,000 -$28,292,000 -88% 31 Mar 2021 10-Q 08 Nov 2022 2022 Q3
Q4 2020 $25,064,000 -$8,707,000 -26% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $26,546,000 -$8,968,000 -25% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $27,999,000 -$9,225,000 -25% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $31,992,000 -$6,132,000 -16% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $33,771,000 +$28,471,000 +537% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $35,514,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $37,224,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $38,124,000 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 $5,300,000 01 Jan 2019 10-K 16 Feb 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.